You searched for Humanized antibody - Page 41 of 45

News and Trends 21 Jan 2016

Fighting Lupus with an Autoimmune Disease Vaccine that Uses Limpet Proteins

…met the CEO of Neovacs, Miguel Sieler, at BIO-Europe in November. Sieler explained how their kinoids are used to stimulate a polyclonal antibody response to a specific cytokine used (depending…

January 21, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 14 Apr 2016

Meet the CEO who wants to transform Pretty Corals into therapies for Cancer

…antibodies – i.e. Antibody Drug Conjugate technology (ADC) – to directly administer the toxin to tumors.This would increase the efficiency of the drug, whilst reducing the number of doses needed,…

April 14, 2016 - 5 minutesmins - By Marie Godar

Best in Biotech 15 May 2018

Here Are 10 of the Hottest Biotech Hubs in Europe

…Planegg. Right there is one of Europe’s largest biotechs: MorphoSys, a billion-euro biotech that develops antibody therapies. The city is also home to Medigene, which develops T cell receptor technology…

May 15, 2018 - 10 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Jan 2025

Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground

…only the three main types but also additional subtypes,” said Rosenthal. Star Therapeutics and VGA039, the new wave in von Willebrand disease? “VGA039 is a first-in-class antibody therapy with a…

January 9, 2025 - 7 minutesmins - By Jules Adam

News and Trends 16 Feb 2016

World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies

Ablynx, the llama antibody biotech in Belgium, has now proven to be on solid ground regarding their orphan drug for a rare blood disease. Now the New England Journal of…

February 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 1 Nov 2022

Human Immunology Biosciences launches with $120M

…enhancements that come with our approach.” Clinical-stage assets HI-Bio’s clinical-stage assets include felzartamab, an anti-CD38 antibody, and HIB210, an anti-C5aR1 antibody. Felzartamab targets a protein expressed on the surface of…

November 1, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 28 Feb 2023

10 biotech companies making a difference in rare diseases

…Founded: 2019 Alchemab Therapeutics is a biotechnology company working on harnessing the power of the immune system to create the next generation of antibody therapeutics for hard-to-treat diseases that do…

February 28, 2023 - 11 minutesmins - By Willow Shah-Neville

In Depth 6 Mar 2023

The biggest private biotech investments in February 2023

…will be used to finance an ongoing phase 1/2 trial of a bispecific antibody treatment for the rare bleeding condition Glanzmann thrombasthenia in addition to the launch of a phase…

March 6, 2023 - 4 minutesmins - By Jonathan Smith

News and Trends 16 Nov 2020

Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal

…deal’s terms, Affimed will receive €51M upfront to license to Roivant a preclinical-stage antibody drug for several undisclosed types of cancer. Roivant will handle the program once Affimed completes preclinical…

November 16, 2020 - 3 minutesmins - By Jonathan Smith

ethris mrna therapy respiratory infection

News and Trends 1 Feb 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

…studies. However, commercializing treatments for viral infections like Covid-19 won’t be plain sailing. For example, Ethris and the Swiss antibody company Neurimmune discontinued the joint development of mRNA treatments encoding…

February 1, 2022 - 3 minutesmins - By Jonathan Smith

In Depth 26 May 2023

Could new Lyme disease tests help to prevent chronic infection?

…order to create a better Lyme disease test. Dr Abdo Alnabulsi, chief executive officer (CEO) of EpitogenX, stated: “We are working on a serology based antibody test for the detection…

May 26, 2023 - 10 minutesmins - By Willow Shah-Neville

News and Trends 17 Mar 2016

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

…are in the race for approval of the first migraine antibody drug. These include Teva (Israel) with the drug called TEV-48125 as well the US based Amgen, Eli Lilly and…

March 17, 2016 - 4 minutesmins - By Ekaterina Perets

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Fighting Lupus with an Autoimmune Disease Vaccine that Uses Limpet Proteins

Meet the CEO who wants to transform Pretty Corals into therapies for Cancer

Here Are 10 of the Hottest Biotech Hubs in Europe

Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground

World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies

Human Immunology Biosciences launches with $120M

10 biotech companies making a difference in rare diseases

The biggest private biotech investments in February 2023

Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Could new Lyme disease tests help to prevent chronic infection?

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!